When you absolutely have to recruit patients on time.
A clinical study of safety and immunogenicity of a vaccine against Hepatitis B in adult healthy subjects is starting at Accell
immunogenicity of a recombinant vaccine against Hepatitis B in adult healthy subjects. Accell will be responsible for regulatory, clinical, data management, statistics and medical writing and will randomize 100 subjects at Russian sites.
This Is Your Team. We Make Clinical Trials Happen.